Minimal Extracorporeal Circuits (MECC) in Cardiac Surgery Procedures

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01306903

Acronym

MECC

Enrollment

Registered

2011-03-02

Start date

2011-03-31

Completion date

2013-06-30

Last updated

2013-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Bloodloss

Keywords

Minimizing Cardiopulmonary Bypass MECC damage organ failure

Brief summary

The standard heart-lung machine is a major trigger of systemic inflammatory reactions, hemodilution, coagulopathy or organ failure. The strict reduction of blood-artificial surface and blood-air contact might represent meaningful improvements of the extracorporeal technology with respect to organ preservation. The aim of this study is the evaluation of potential differences between a minimal extracorporeal circuit (MECC) and a conventional cardiopulmonary bypass (MOPS) system.

Interventions

DEVICEMECC

Minimized extracorporeal circulation

DEVICEMOPS

Modified and optimized perfusion system Frankfurt

DEVICESuper MOPS

Super modified and optimized perfusion system Frankfurt

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* extracorporeal circulation * age \> 18 years old

Design outcomes

Primary

Measure	Time frame	Description
Bloodloss	postoperative	Count of red blood packages

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026